Search research articles

Search research articles

Related Experiment Videos

Tissue-engineered skin substitutes.

¹Advanced Tissue Sciences, Inc., 10933 North Torrey Pines Road, La Jolla, CA 92037, USA. jonathan.mansbridge@advancedtissue.com.

Expert Opinion on Investigational Drugs

|July 5, 2005

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Miniature laser light scattering instrumentation for particle size analysis.

Applied optics·2010

Same author

Miniature, solid state photon correlation laser Doppler velocimetry.

Applied optics·2010

Same author

Skin substitutes to enhance wound healing.

Expert opinion on investigational drugs·2005

Same author

Overexpression of trehalose synthase and accumulation of intracellular trehalose in 293H and 293FTetR:Hyg cells.

Cryobiology·2002

Same author

SB203580 promotes EGF-stimulated early morphological differentiation in PC12 cell through activating ERK pathway.

Journal of cellular biochemistry·2001

Same author

Modification of fibroblast gamma-interferon responses by extracellular matrix.

The Journal of investigative dermatology·2001

Same journal

Advancements in longevity pharmacology research - are we finally seeing clinical progression?

Expert opinion on investigational drugs·2026

Same journal

Consideration of the use of nalbuphine in idiopathic pulmonary fibrosis-associated cough: to cough or not to cough so much?

Expert opinion on investigational drugs·2026

Same journal

Investigational new drug TAP-1502 beginning clinical study for seborrheic dermatitis.

Expert opinion on investigational drugs·2026

Same journal

Cannabinoid use in adults with sickle cell disease: therapeutic development and clinical insights.

Expert opinion on investigational drugs·2026

Same journal

Odronextamab: a bispecific antibody for follicular lymphoma.

Expert opinion on investigational drugs·2026

Same journal

Evaluating the investigational drug landscape for <i>ESR1</i>-mutated, estrogen receptor-positive, HER2-negative metastatic breast cancer.

Expert opinion on investigational drugs·2026

See all related articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Tissue engineered skin substitutes are advanced, with research focusing on expanding wound treatment applications. A key innovation includes adding endothelial cells to promote vascularization in engineered skin.

Area of Science:

Biomedical Engineering
Regenerative Medicine
Dermatology

Background:

Tissue engineered skin substitutes represent a mature field of research.
Current efforts focus on broadening the applications of existing skin substitute technologies.

Purpose of the Study:

To explore the expanding indications for tissue engineered skin substitutes.
To highlight recent compositional advancements in skin substitute development.

Main Methods:

Review of current research trends in tissue engineered skin substitutes.
Analysis of novel approaches for wound healing and tissue augmentation.

Main Results:

Research is extending applications to acute, chronic, surgical, and cosmetic wounds.

Related Experiment Videos

New uses include soft tissue augmentation and gene delivery.

Inclusion of endothelial cells facilitates host vascularization.

Conclusions:

Tissue engineered skin substitutes are nearing full clinical utility.
Endothelial cell incorporation is a significant advancement for vascularization.
Further research will expand treatment possibilities for diverse wound types.